earnings slide as tech spending doubles
Dis-Chem doubled its spending on X, bigly labs, its in-house technology and innovation unit, in the six months to August. The pharmacy group’s earnings fell again, even though revenue grew 8%. Headline earnings per share dropped 12.8% to 64.3c, Dis-Chem said in its interim results published after markets closed on Thursday. Revenue rose 8% to…
